1. Home
  2. AKTX vs NSYS Comparison

AKTX vs NSYS Comparison

Compare AKTX & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • NSYS
  • Stock Information
  • Founded
  • AKTX N/A
  • NSYS 1981
  • Country
  • AKTX United States
  • NSYS United States
  • Employees
  • AKTX N/A
  • NSYS N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • NSYS Industrial Machinery/Components
  • Sector
  • AKTX Health Care
  • NSYS Technology
  • Exchange
  • AKTX Nasdaq
  • NSYS Nasdaq
  • Market Cap
  • AKTX 35.7M
  • NSYS 24.7M
  • IPO Year
  • AKTX N/A
  • NSYS N/A
  • Fundamental
  • Price
  • AKTX $1.08
  • NSYS $8.79
  • Analyst Decision
  • AKTX
  • NSYS
  • Analyst Count
  • AKTX 0
  • NSYS 0
  • Target Price
  • AKTX N/A
  • NSYS N/A
  • AVG Volume (30 Days)
  • AKTX 22.7K
  • NSYS 33.8K
  • Earning Date
  • AKTX 08-18-2025
  • NSYS 08-07-2025
  • Dividend Yield
  • AKTX N/A
  • NSYS N/A
  • EPS Growth
  • AKTX N/A
  • NSYS N/A
  • EPS
  • AKTX N/A
  • NSYS N/A
  • Revenue
  • AKTX N/A
  • NSYS $120,813,000.00
  • Revenue This Year
  • AKTX N/A
  • NSYS N/A
  • Revenue Next Year
  • AKTX N/A
  • NSYS N/A
  • P/E Ratio
  • AKTX N/A
  • NSYS N/A
  • Revenue Growth
  • AKTX N/A
  • NSYS N/A
  • 52 Week Low
  • AKTX $0.85
  • NSYS $7.25
  • 52 Week High
  • AKTX $4.40
  • NSYS $15.55
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 41.09
  • NSYS 47.90
  • Support Level
  • AKTX $1.10
  • NSYS $9.00
  • Resistance Level
  • AKTX $1.15
  • NSYS $9.49
  • Average True Range (ATR)
  • AKTX 0.03
  • NSYS 0.44
  • MACD
  • AKTX 0.00
  • NSYS 0.00
  • Stochastic Oscillator
  • AKTX 10.00
  • NSYS 38.26

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

Share on Social Networks: